A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer

The combination of docetaxel, cisplatin, and S-1 (DCS) is a common chemotherapy regimen for patients with gastric cancer (GC). However, studies on long noncoding RNAs (lncRNAs) associated with the chemotherapeutic response to and prognosis after DCS remain lacking. The aim of the present study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Li, Leyan, Tu, Yi, Feng, Zongfeng, Li, Zhengrong, Cao, Yi, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446389/
https://www.ncbi.nlm.nih.gov/pubmed/35993308
http://dx.doi.org/10.1042/BSR20220989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446389/
https://www.ncbi.nlm.nih.gov/pubmed/35993308
http://dx.doi.org/10.1042/BSR20220989

Ejemplares similares